Skip to content

To study the effect of Panchakarma Essential in reducing symptoms with cardiopulmonary disorders

A clinical study to evaluate the Safety and Efficacy of Panchakarma Essential in reducing symptoms with Cardiopulmonary Disorders - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/060197
Enrollment
30
Registered
2023-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I249- Acute ischemic heart disease, unspecified

Interventions

Intervention1: Murchit oil: To be applied on chest area for 7 days Control Intervention1: Standard Murchit oil: To be applied on chest area for 7 days

Sponsors

Mprex Healthcare Pvt.Ltd. Wakad, pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and female subjects 30-60 years of age (both inclusive).2.Subjects diagnosed with Ischemic Heart Disease, Post Myocardial infarction, and Insomnia will be included.3.Subjects with pulse rate more than 90 per minute.4.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures.

Exclusion criteria

Exclusion criteria: 1.Female subjects, who are pregnant, breastfeeding, or planning to become pregnant. 2.History of major surgical intervention will be excluded. 3.History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
1.To study the efficacy of Panchakarma Essential in reducing cardiopulmonary disorders. 2. To assess the improvement in circulation of blood in the body & cardio-respiratory functions.Timepoint: Seven Sessions in two week period

Secondary

MeasureTime frame
1.To assess the improvement in insomnia. 2.To assess the improvement in the Quality of life of a patient.Timepoint: Seven Sessions in two week period

Countries

India

Contacts

Public ContactDr Vaishnavi Patil

Mprex Healthcare Pvt. Ltd.

vaishnavi@mprex.in9834585994

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026